Pfizer and Innovent will co-develop four programmes globally and share the development costs. The companies will ...

June is PRIDE month and EMA starts a two-month celebration of diversity and inclusion in science and healthcare, leading up ...

Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the treatment of androgenetic alopecia, into phase 3 trials. PP405 is a ...

For pharma brands, AI visibility is no longer just a digital question, it is fast becoming a brand strategy imperative ...

Eli Lilly is to acquire LimmaTech Biologics and Vaccine Company. Along with its acquisition of Curevo, the companies will ...

The National Institute for Health and Care Excellence (NICE) has recommended Genmab UK’s Tivdak (tisotumab vedotin) for ...

Moderna has appointed Piyali Mukherjee as Head of Medical Affairs, Europe and Middle East. She will be based in Switzerland ...

UK market access needs the right conditions nationally, along with subnational investment and delivery locally ...

Eli Lilly has announced that it will acquire Curevo to expand the company’s research and development efforts into infectious ...

Delphia Therapeutics has appointed David Kerstein as Chief Medical Officer (CMO). Delphia is a biopharmaceutical company pioneering an innovative new area of cancer biology – activation lethality – ...

This year, we welcome Simon Bates as the new Chair of the judging panel, someone who has been a judge and steering group ...